LINZESS 145 MCG CAPSULE

linaclotide
$9.0282per EA

Strength

145 ug/1

Manufacturer

Allergan, Inc.

NDC

00456120130

Classification

Brand

Dosage Form

CAPSULE, GELATIN COATED

Route

ORAL

Last Updated

1/1/2026

Active Ingredients

LINACLOTIDE

Approval Type

New Drug (NDA)

FDA Application

NDA202811

On Market Since

9/8/2012

Pharmacological Classes

Guanylate Cyclase Activators
Guanylate Cyclase-C Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-50.3%

1Y

-50.3%

3Y

-45.3%

5Y

-39.6%

All

+31.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.